Stay updated on GDC-6036 in KRAS G12C+ Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the GDC-6036 in KRAS G12C+ Solid Tumors Clinical Trial page.

Latest updates to the GDC-6036 in KRAS G12C+ Solid Tumors Clinical Trial page
- Check6 days agoNo Change Detected
- Check14 days agoChange DetectedThe page has been updated to reflect current operating status and a new revision (v3.2.0), replacing the previous date and version (v3.1.0). The update also adds a government funding notice and current date, while removing the older date and revision.SummaryDifference10%
- Check21 days agoChange DetectedUpdated the page revision from v3.0.2 to v3.1.0, indicating a new software release or document update. No changes to core content, pricing, or stock are evident.SummaryDifference0.2%
- Check28 days agoNo Change Detected
- Check35 days agoChange DetectedRevision updated to v3.0.2 from v3.0.1; the 'Back to Top' link was removed. No substantive changes to pricing, stock, or core page content.SummaryDifference0.5%
- Check42 days agoChange DetectedThe page has been updated to reflect a new revision version (v3.0.1) and a new study status date of September 1, 2025, while the previous revision version (v3.0.0) and an earlier date of August 3, 2025, have been removed.SummaryDifference1%
- Check49 days agoChange DetectedThe web page has undergone significant updates, including the addition of a facility name and location details, while removing specific state, country, and city information.SummaryDifference54%
- Check64 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.3%
Stay in the know with updates to GDC-6036 in KRAS G12C+ Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the GDC-6036 in KRAS G12C+ Solid Tumors Clinical Trial page.